Role of μ-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine- sensitized mice

Journal of Neuroscience Research

Volumn 85, Issue 3, 2007, Pages 673-680

  Tien, Lu Tai ^a,c   Ho, Ing Kang ^a   Loh, Horace H ^b   Ma, Tangeng ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Autoradiography; In situ hybridization; METH induced sensitization; Preproenkephalin; Psychostimulants

Indexed keywords

DOPAMINE RECEPTOR; MESSENGER RNA; METHAMPHETAMINE; MU OPIATE RECEPTOR; PREPROENKEPHALIN;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; BRAIN TISSUE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG MECHANISM; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION;

ANIMALS; ENKEPHALINS; GENE EXPRESSION REGULATION; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NUCLEIC ACID HYBRIDIZATION; PROTEIN PRECURSORS; RECEPTORS, DOPAMINE; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 33847312717     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21145     Document Type: Article

References (41)

1. Angulo JA, Davis LG, Burkhart BA, Christoph GR. 1986. Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA. Eur J Pharmacol 130:341-343.
2. Caboche J, Vernier P, Julien JF, Rogard M, Mallet J, Besson MJ. 1991. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist. J Neurochem 56:428-435.
3. Chiu CT, Ma T, Ho IK. 2005. Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. Brain Res Bull 67:100-109.
4. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M. 1996. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48:567-592.
5. 1-opioid receptor binding in the rat brain. Brain Res Bull 58:149-160.
6. Gerfen CR, McGinty JF, Young WS III. 1991. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11:1016-1031.
7. Gibb JW, Johnson M, Hanson GR. 1990. Neurochemical basis of neurotoxicity. Neurotoxicology 11:317-321.
8. Graham WC, Crossman AR, Woodruff GN. 1990. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Brain Res 514:93-102.
9. Herz A. 1998. Opioid reward mechanisms: a key role in drug abuse? Can J Physiol Pharmacol 76:252-258.
10. Horner KA, Adams DH, Hanson GR, Keefe KA. 2005. Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion. Neuroscience 131:67-77.
11. Huang YH, Tsai SJ, Huang HJ, Sim CB. 1997. Effects of amphetamine challenge on local cerebral glucose utilization after chronic dopamine D1 and D2 receptor agonist administration to rats. Eur J Pharmacol 338:117-121.
12. Hyttel J. 1986. Effect of prolonged treatment with neuroleptics on dopamine D1 and D2 receptor density in corpus striatum of mice. Acta Pharmacol Toxicol 59:387-391.
13. Itzhak Y, Ali SF. 2002. Behavioral consequences of methamphetamine- induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Ann N Y Acad Sci 965:127-135.
14. Itzhak Y, Martin JL, Ali SF. 2002. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 26:1177-1183.
15. Jamensky NT, Gianoulakis C. 1999. Comparison of the proopiomelanocortin and proenkephalin opioid peptide systems in brain regions of the alcohol-preferring C57BL/6 and alcohol-avoiding DBA/2 mice. Alcohol 18:177-187.
16. Kitchen I, Slowe SJ, Matthes HW, Kieffer B. 1997. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 778:73-88.
17. Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI. 1995. Molecular biology and pharmacology of cloned opioid receptors. FASEB J 9:516-525.
18. Lena I, Matthes H, Kieffer B, Kitchen I. 2004. Quantitative autoradiography of dopamine receptors in the brains of μ-opioid receptor knockout mice. Neurosci Lett 356:220-224.
19. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. 1998. μ-Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54:321-326.
20. Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubie M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL. 1998. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J Neurosci 18:7285-7295.
21. Mocchetti I, Naranjo JR, Costa E. 1987. Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes. J Pharmacol Exp Ther 241:1120-1124.
22. Ongali B, Ase AR, Hebert C, Amdiss F, Reader TA. 2000. Dopamine D1 and D2 receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents. Synapse 37:1-15.
23. Ozaki S, Narita M, Narita M, Iino M, Sugita J, Matsumura Y, Suzuki T. 2002. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area. J Neurochem 82:1192-1198.
24. Park Y, Ho IK, Fan LW, Loh HH, Ko KH. 2001. Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of μ-opioid receptor knockout mice. Brain Res 894:311-315.
25. Phillips TJ, Dickinson S, Burkhart-Kasch S. 1994. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 108:789-803.
26. Pollack AE, Wooten GF. 1992. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Brain Res Mol Brain Res 12:111-119.
27. Qian Y, Hitzemann B, Hitzemann R. 1992. D1 and D2 dopamine receptor distribution in the neuroleptic nonresponsive and neuroleptic responsive lines of mice, a quantitative receptor autoradiographic study. J Pharmacol Exp Ther 261:341-348.
28. Robinson TE, Becker JB. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198.
29. Rubinstein M, Muschietti JP, Gershanik O, Flawia MM, Stefano FJ. 1990. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice. J Pharmacol Exp Ther 252:810-816.
30. Satoh M, Minami M. 1995. Molecular pharmacology of the opioid receptors. Pharmacol Ther 68:343-364.
31. Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW. 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 233:539-544.
32. Shen X, Tien L, Loh HH, Ho IK, Ma T. 2005. Methamphetamine-induced behavioral sensitization in μ-opioid receptor knockout mice. Soc Neurosci Abstr 300.2.
33. Spanagel R, Herz A, Shippenberg TS. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89:2046-2050.
34. Tang F, Costa E, Schwartz JP. 1983. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80:3841-3844.
35. Tien LT, Park Y, Fan LW, Ma T, Loh HH, Ho IK. 2003. Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in μ-opioid receptor knockout mice. Brain Res Bull 61:109-115.
36. Tsao LI, Ladenheim B, Andrews AM, Chiueh CC, Cadet JL, Su TP. 1998. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species. J Pharmacol Exp Ther 287:322-331.
37. Ujike H, Akiyama K, Otsuki S. 1990. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology 102:459-464.
38. Wang JQ, McGinty JF. 1995. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain. J Neurochem 65:2706-2715.
39. Wang JQ, McGinty JF. 1996. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22:114-122.
40. 3H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study. Neuroscience 109:709-716.
41. Zeng BY, Pearce RK, MacKenzie GM, Jenner P. 2001. Chronic high dose L-dopa treatment does not alter the levels of dopamine D1, D2 or D3 receptor in the striatum of normal monkeys: an autoradiographic study. J Neural Transm 108:925-941.